In a boost to the Centre's ‘Make in India’ initiative, indigenously developed medical technology has reached a new milestone, with a team of surgeons performing a beating-heart bypass procedure using a five-arm robotic system.
In a boost to the Centre's ‘Make in India’ initiative, indigenously developed medical technology has reached a new milestone, with a team of surgeons performing a beating-heart bypass procedure using a five-arm robotic system.
The surgery was carried out without stopping the heart or opening the chest through the conventional method.
The procedure, performed at Medanta Hospital in Gurugram, Haryana, recently using the indigenous SSI Mantra robotic system, is being described as the world's first dual-console, five-arm robotic beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB) surgery.
The achievement is being considered significant, as it brings together several complex elements of heart surgery. The patient's heart continued beating throughout the procedure, and the surgeons did not use a heart-lung machine. Instead of making a large cut through the breastbone, they operated through small incisions, using robotic arms and a camera to guide the instruments.
The dual-console system also allowed two surgeons to operate and coordinate during the procedure. The procedure was performed by Dr Nitin Kumar Rajput, Associate Director of Robotic and Minimally Invasive Cardiac Surgery at Medanta, Gurugram, and Dr Lalit Malik, Chief Cardiac Surgeon at Manipal Hospital, Jaipur, under the supervision of Dr Sudhir Srivastava, Founder, Chairman and CEO of SS Innovations International, widely regarded as the Father of Robotic Surgery in India.
Dr Rajput said that the robotic systems can help surgeons perform delicate movements with greater precision and view the operating area in detail.
“In selected patients, minimally invasive procedures may also mean less surgical trauma and a shorter recovery period,” added Dr Srivastava.
There is also a need to establish which patients are suitable for robotic bypass surgery and compare their outcomes, complications, recovery time and long-term results with those of established surgical methods. Not every patient with blocked heart arteries will be a candidate for this approach, he added.
Dr Srivastava pointed out that the cost of disposables and instruments was approximately one-third that of comparable robotic systems. However, he added, this should not be confused with the total cost of an operation. The final bill also includes the hospital stay, medical team, equipment, investigations and other expenses.
For the technology to make a wider difference, hospitals will need to bring down the overall cost of treatment, he emphasised. Public hospitals and medical colleges will also need access to such systems, along with trained surgeons, nurses and technicians. Training more teams and building the supporting infrastructure outside major cities will be equally important, noted Dr Srivastava.
The possibility of remote surgical guidance and training could eventually help specialists support teams in smaller centres. But such arrangements require reliable high-speed connectivity, strict patient-safety protocols and clear medical responsibility. They cannot replace the need for skilled local teams and well-equipped hospitals, he clarified.
“Robotic systems can help surgeons perform delicate movements with greater precision and view the operating area in detail. In selected patients, minimally invasive procedures may also mean less surgical trauma and a shorter recovery period. However, the benefits and risks depend on the patient's condition, the complexity of the surgery and the experience of the surgical team,” said Dr Srivastava.